Preclinical studies on comorbidity between depression and psychostimulant addiction.
Journal Title: Pharmacological Reports - Year 2013, Vol 65, Issue 6
Abstract
Several clinical data indicate that depression is frequently comorbid with psychostimulant (cocaine, amphetamines) addiction. This short review summarizes preclinical results and observations showing how reward processes are modified in animal models of depression, and which depression-like effects are induced in experimental animals withdrawn from chronic treatment with psychostimulants.
Authors and Affiliations
Małgorzata Filip, Joanna Jastrzębska, Karolina Wydra, Edmund Przegaliński
Keywords
Related Articles
- EP ID EP136550
- DOI -
- Views 111
- Downloads 0
Mechanisms of platelet-activating factor (PAF)-mediated responses in the lung.
Platelet-activating factor (PAF) is a potent lipid mediator that has been implicated in asthma, sepsis, acute lung injury and ischemia/reperfusion injury. Its actions in the lungs include vasoconstriction, bronchoconstri...
Anxiolytic-like effects of olanzapine, risperidone and fluoxetine in the elevated plus-maze test in rats.
In the present study was examined the effect of treatment with olanzapine or risperidone, given separately or in combination with fluoxetine, in the elevated plus-maze test (an animal model of anxiety) in male Wistar rat...
Caffeine metabolism during prolonged treatment of rats with antidepressant drugs.
Our previous studies showed that some of the tested antidepressants (tricyclics, SSRIs, mirtazapine, nefazodone) directly inhibited the metabolism of caffeine when added in vitro to liver microsomes. The aim of the prese...
Statin-induced myopathies.
Statins are considered to be safe, well tolerated and the most efficient drugs for the treatment of hypercholesterolemia, one of the main risk factor for atherosclerosis, and therefore they are frequently prescribed medi...
Atherosclerotic risk among children taking antiepileptic drugs.
Epilepsy is a common chronic neurological disorder that requires long-term or sometimes lifetime therapy. Recent evidence indicates that prolonged use of antiepileptic drugs (AEDs) might modify some vascular risk factors...